Small Molecules

26 Jun 2007 Metabasis Therapeutics Presents Preclinical Data on CS-917 and MB07811 at the American Diabetes Association Meeting
26 Jun 2007 Genaera Presents Preclinical Data On Trodusquemine (msi-1436) For The Treatment Of Obesity At The American Diabetes Association 67th Scientific Session
26 Jun 2007 Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
26 Jun 2007 Theravance Announces Positive Results from Phase 2 Clinical Study in Chronic Constipation with Investigational Compound TD-5108
26 Jun 2007 Second Phase III Study Evaluating Gilead's Viread(R) for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
26 Jun 2007 Molecular Insight Pharmaceuticals, Inc. Initiates First of Two Planned Pivotal Registration Trials for Zemiva(TM) in Detection of Cardiac Ischemia
26 Jun 2007 Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Association's Annual Meeting
24 Jun 2007 Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset(TM) (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes
24 Jun 2007 Orexigen(TM) Therapeutics Reports Contrave(TM) Has Positive Effect on Visceral Fat and Insulin Resistance, Factors Believed to Contribute to the Risk of Heart Disease and Type II Diabetes
24 Jun 2007 Takeda's Investigational DPP-4 Inhibitor Demonstrated Efficacy in Reducing Glucose Levels in Early Phase Study
23 Jun 2007 Rasilez(R), an important new treatment for high blood pressure, receives positive opinion recommending European Union approval
23 Jun 2007 Pfizer's Lyrica Receives FDA Approval for Fibromyalgia
22 Jun 2007 S*BIO becomes Singapore's first biotech company to initiate clinical trial of novel anti-cancer drug
22 Jun 2007 Shire Receives Approvable Letter from FDA for INTUNIV(TM) (guanfacine) Extended Release, a Nonstimulant for the Treatment of ADHD
22 Jun 2007 LifeCycle Pharma to Initiate Phase II Clinical Trial of LCP-Tacro for Organ Transplantation
22 Jun 2007 FDA Issues Approvable Letter for RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania
22 Jun 2007 LAB International licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe
22 Jun 2007 VIVUS Completes End of Phase 2 Meeting with the FDA for Qnexa, a Treatment for Obesity
22 Jun 2007 Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
22 Jun 2007 4SC AG achieves proof of concept for drug candidate SC12267
22 Jun 2007 Exforge(R) receives final US approval as new and powerful treatment option for patients with high blood pressure
22 Jun 2007 Kinex Files IND for KX2-391 with the US Food and Drug Administration
22 Jun 2007 Icagen Receives Notification from McNeil of Termination of Collaboration Agreement
21 Jun 2007 Metabasis Therapeutics Announces Initiation of a Clinical Trial for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia
21 Jun 2007 Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top